ClinicalTrials.gg

Head and Neck Neoplasms clinical trials

The registry lists 2,716 studies for Head and Neck Neoplasms across more than 10 countries. 598 are recruiting or about to start. 1,518 of them are mainly about Head and Neck Neoplasms (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-17. Counting its 24 narrower conditions too, such as Squamous Cell Carcinoma of Head and Neck: 8,925 studies, 2,539 open.

ClinicalTrials.gov finds 8,825 studies for Head and Neck Neoplasms. How that becomes 2,713 here

This page counts the studies the registry files under Head and Neck Neoplasms, and those it files under no condition that list Head and Neck Neoplasmsthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 15, 2026. How condition pages count

  1. 8,825Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −5,680Filed under a narrower condition, counted on its own pageEsophageal Neoplasms 1,707 · Squamous Cell Carcinoma of Head and Neck 1,316 · Thyroid Neoplasms 644 · Nasopharyngeal Carcinoma 603 · Esophageal Squamous Cell Carcinoma 432 · Mouth Neoplasms 215 · 15 more
  3. −32List Head and Neck Neoplasms as a condition, but the registry did not file them under itMost often written as “Head and Neck Cancer Squamous Cell Carcinoma” (7), “Squamous Cell Cancer of Head and Neck (SCCHN)” (5), and “Squamous Cell Cancer of Head and Neck” (3). The registry filed 21 of them under no condition at all, and the others under other conditions only, most often Carcinoma, Non-Small-Cell Lung (5) and Melanoma (5).
  4. −400Match it another way196 name it in the title, 2 in a keyword, and 202 by a synonym or other text the search reads.
  5. 2,713The count on this page

Get an email when these change. Save the Head and Neck Neoplasms studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Status

Completed
1,323
Recruiting
456
Terminated
281
Status unknown
246
Active, not recruiting
152
Not yet recruiting
124

Phase

Phase 2
835
Phase 1
527
Phase 3
209
Early Phase 1
58
Phase 4
45

Where

United States
1,317
France
236
Canada
202
China
173
United Kingdom
151
Italy
134

What is being tested here

Drugs under test in Head and Neck Neoplasms studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug classes tested here Immune checkpoint inhibitors 38 open · Antimitotic agents 12 open · Tyrosine kinase inhibitors (TKIs) 8 open · Antimetabolites 7 open · NSAIDs 4 open

Coming up

218studies finish main data collection within a year8 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 456 Head and Neck Neoplasms studies recruiting now, 348 (76%) set no upper age limit and 51 (11%) stop at 75 or younger. 22 (5%) take children under 18. 1 (<1%) are for women only and 0 (0%) for men only; 27 (6%) take healthy volunteers.

Recruiting studies that take each age, of 456
AgeWomenMen
1017 (4%)16 (4%)
18430 (94%)429 (94%)
30450 (99%)449 (98%)
40451 (99%)450 (99%)
50451 (99%)450 (99%)
65451 (99%)450 (99%)
75443 (97%)442 (97%)
85376 (82%)375 (82%)

Across all 2,716 studies, recruiting or not: 10% stop at 75 or younger and 2% at 65; 6% take children; <1% are for women only and <1% for men only; 5% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Head and Neck Neoplasms studies take

Of 260 phase 2 interventional studies under Head and Neck Neoplasms, half reached primary completion within 51 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 145 mo31–65 · 177 studies45 mo29–66 · 86 studies42 mo32–63 · 91 studies
Phase 1/254 mo41–79 · 90 studies55 mo44–78 · 51 studies54 mo31–97 · 39 studies
Phase 251 mo30–76 · 260 studies32 mo20–45 · 44 studies57 mo37–84 · 216 studies
Phase 361 mo34–100 · 66 studies—76 mo53–108 · 48 studies
Interventional, no phase33 mo18–71 · 457 studies—34 mo18–71 · 439 studies
Observational69 mo29–144 · 238 studies—71 mo27–144 · 216 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 18, 2026.

Started recruiting12

Show 7 more

Newly registered26

Show 21 more

Studies

Recruiting first, then most recently updated. Showing 50 of 2,716. Browse all 2,716 → or search them.